1Danzeisen, R, Araya, M, Harrison, B, Keen, C, Solioz, M, Thiele, D & McArdle, HJM (2007) How reliable and robust are current biomarkers for copper status? Br J Nutr 98, 676–683.
2Nishihara, E, Furuyama, T, Yamashita, S & Mori, N (1998) Expression of copper trafficking genes in the mouse brain. Neuroreport 9, 3259–3263.
3Kuo, YM, Gybina, AA, Pyatskowit, JW, Gitschier, J & Prohaska, JR (2006) Copper transport protein (Ctr1) levels in mice are tissue specific and dependent on copper status. J Nutr 136, 21–26.
4Rae, TD, Schmidt, PJ, Pufahl, RA, Culotta, VC & O'Halloran, TV (1999) Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science 284, 805–808.
5Brewer, GJ (2007) Iron and copper toxicity in diseases of aging, particularly atherosclerosis and Alzheimer's disease. Exp Biol Med (Maywood) 232, 323–335.
6Phinney, AL, Drisaldi, B, Schmidt, SD, et al. (2003) In vivo reduction of amyloid-β by a mutant copper transporter. Proc Natl Acad Sci U S A 100, 14193–14198.
7Bayer, TA, Schafer, S, Simons, A, et al. (2003) Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice. Proc Natl Acad Sci U S A 100, 14187–14192.
8Pajonk, FG, Kessler, H, Supprian, T, et al. (2005) Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer's disease. J Alzheimers Dis 8, 23–27.
9Squitti, R, Ventriglia, M, Barbati, G, et al. (2007) ‘Free’ copper in serum of Alzheimer's disease patients correlates with markers of liver function. J Neural Transm 114, 1589–1594.
10Religa, D, Strozyk, D, Cherny, RA, Volitakis, I, Haroutunian, V, Winblad, B, Naslund, J & Bush, AI (2006) Elevated cortical zinc in Alzheimer disease. Neurology 67, 69–75.